Citigroup’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14M Sell
66,493
-28,759
-30% -$7.23M 0.01% 1270
2025
Q4
$27.1M Buy
95,252
+5,370
+6% +$1.68M 0.01% 942
2025
Q3
$27.7M Buy
89,882
+4,862
+6% +$1.52M 0.01% 898
2025
Q2
$26.7M Buy
85,020
+4,008
+5% +$1.16M 0.01% 828
2025
Q1
$21.3M Buy
81,012
+16,931
+26% +$4.58M 0.01% 940
2024
Q4
$16.7M Buy
64,081
+145
+0.2% +$36.5K 0.01% 1059
2024
Q3
$14.9M Sell
63,936
-1,159
-2% -$238K 0.01% 1114
2024
Q2
$13.1M Buy
65,095
+2,087
+3% +$376K 0.01% 1104
2024
Q1
$10.8M Buy
63,008
+29,403
+87% +$5.48M 0.01% 1208
2023
Q4
$7.29M Sell
33,605
-1,334
-4% -$229K 0.01% 1373
2023
Q3
$5.57M Buy
34,939
+2,739
+9% +$613K ﹤0.01% 1370
2023
Q2
$9.28M Buy
32,200
+225
+0.7% +$68.3K 0.01% 1163
2023
Q1
$10.2M Buy
31,975
+2,549
+9% +$756K 0.01% 1149
2022
Q4
$8.66M Sell
29,426
-5,288
-15% -$1.46M 0.01% 1206
2022
Q3
$7.96M Sell
34,714
-2,303
-6% -$577K 0.01% 1261
2022
Q2
$8.07M Sell
37,017
-7,709
-17% -$1.75M 0.01% 1261
2022
Q1
$11.9M Sell
44,726
-2,985
-6% -$733K 0.01% 1215
2021
Q4
$12.7M Sell
47,711
-3,523
-7% -$1.02M 0.01% 1253
2021
Q3
$14.6M Buy
51,234
+4,285
+9% +$1.22M 0.01% 1190
2021
Q2
$12.9M Sell
46,949
-12,564
-21% -$3.42M 0.01% 1260
2021
Q1
$15.5M Buy
59,513
+16,922
+40% +$4.53M 0.01% 1097
2020
Q4
$10.9M Buy
42,591
+9,040
+27% +$2.24M 0.01% 1486
2020
Q3
$7.94M Buy
33,551
+2,642
+9% +$556K 0.01% 1555
2020
Q2
$6M Buy
30,909
+15,236
+97% +$2.91M ﹤0.01% 1695
2020
Q1
$2.6M Sell
15,673
-5,092
-25% -$930K ﹤0.01% 2240
2019
Q4
$3.56M Sell
20,765
-8,453
-29% -$1.41M ﹤0.01% 2346
2019
Q3
$4.82M Sell
29,218
-40,804
-58% -$5.73M ﹤0.01% 1978
2019
Q2
$8.36M Buy
70,022
+59,942
+595% +$6.15M 0.01% 1532
2019
Q1
$959K Sell
10,080
-18,188
-64% -$1.56M ﹤0.01% 3440
2018
Q4
$2.24M Buy
28,268
+19,141
+210% +$1.62M ﹤0.01% 2562
2018
Q3
$967K Buy
9,127
+7,339
+410% +$687K ﹤0.01% 3539
2018
Q2
$153K Buy
1,788
+41
+2% +$3.68K ﹤0.01% 5312
2018
Q1
$151K Sell
1,747
-162
-8% -$12.6K ﹤0.01% 5238
2017
Q4
$131K Buy
1,909
+191
+11% +$12.5K ﹤0.01% 5410
2017
Q3
$94K Sell
1,718
-694
-29% -$37.9K ﹤0.01% 5617
2017
Q2
$124K Sell
2,412
-10,821
-82% -$470K ﹤0.01% 5171
2017
Q1
$571K Buy
+13,233
New +$568K ﹤0.01% 3751
2016
Q4
Sell
-17,865
Closed -$731K 7289
2016
Q3
$731K Buy
17,865
+17,598
+6,591% +$696K ﹤0.01% 3548
2016
Q2
$8K Sell
267
-39,577
-99% -$1.23M ﹤0.01% 6638
2016
Q1
$1.32M Buy
39,844
+39,711
+29,858% +$1.25M ﹤0.01% 2993
2015
Q4
$5K Sell
133
-998
-88% -$33.6K ﹤0.01% 7056
2015
Q3
$29K Sell
1,131
-1,420
-56% -$43.1K ﹤0.01% 5777
2015
Q2
$79K Sell
2,551
-6,444
-72% -$190K ﹤0.01% 5192
2015
Q1
$300K Buy
8,995
+3,031
+51% +$102K ﹤0.01% 4161
2014
Q4
$275K Sell
5,964
-966
-14% -$41.3K ﹤0.01% 4429
2014
Q3
$256K Sell
6,930
-10,824
-61% -$395K ﹤0.01% 4049
2014
Q2
$705K Sell
17,754
-418
-2% -$16.1K ﹤0.01% 3232
2014
Q1
$861K Buy
18,172
+11,763
+184% +$520K ﹤0.01% 2993
2013
Q4
$238K Buy
6,409
+1,669
+35% +$61.7K ﹤0.01% 4500
2013
Q3
$172K Sell
4,740
-2,754
-37% -$92.4K ﹤0.01% 4282
2013
Q2
$236K Buy
+7,494
New +$212K ﹤0.01% 4126

Other funds holding PODD

Citigroup's PODD Position: Q1 2026 in Review

Citigroup reduced its Insulet (PODD) stake by 30% in Q1 2026, selling an estimated $7.23M and leaving 66,493 shares worth $14M. The position accounts for 0.01% of the portfolio, ranked #1270.

Citigroup first reported a position in PODD in Q2 2013 and has held it in 51 quarters since. The position peaked at $27.7M in Q3 2025. 785 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • Citigroup held 66,493 shares of Insulet worth $14M as of Q1 2026.
  • Citigroup sold 28,759 Insulet shares in Q1 2026, an estimated $7.23M.
  • Insulet made up 0.01% of Citigroup's portfolio in Q1 2026, its #1270 holding.
  • Citigroup first reported a position in Insulet in Q2 2013 and has held it in 51 quarters since.
  • Citigroup's Insulet position peaked at $27.7M in Q3 2025.
  • 785 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.